| [1] | GROENEWEGEN KH,SCHOLS AM,WOUTERS EF.Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD[J].Chest,2003,124(2):459. |
| [2] | ROCHAT T,CHARBONNIER F,PLOJOUX J.New therapeutic approaches in 2014 in pulmonary medicine:COPD,asthma and lung fibrosis[J].Rev Med Suisse,2015,11(457):129. |
| [3] | WALTERS JA,TAN DJ,WHITE CJ,et al.Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease[J].Cochrane Database Syst Rev,2014,12(10):CD006897. |
| [4] | FOO J,LANDIS SH,MASKELL J,et al.Continuing to confront COPD international patient survey:economic impact of COPD in 12 countries[J].PLoS One,2016,11(4):e0152618. |
| [5] | 危蕾,钱叶长,刘芳英,等.厄多司坦与氨溴索治疗慢性阻塞性肺疾病的疗效及安全性对照研究[J].蚌埠医学院学报,2009,34(6):507. |
| [6] | MORETTI M.Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease[J].Expert Rev Respir Med,2007,1(3):307. |
| [7] | DAL NEGRO RW,VISCONTI M,TOGNELLA S,et al.Erdosteine affects eicosanoid production in COPD[J].Int J Clin Pharmacol Ther,2011,49(1):41. |
| [8] | 余薇,李天林,吕骁.布地奈德福莫特罗吸入联合厄多司坦在极重度COPD稳定期的疗效研究[J].中外医疗,2015,34(28):130. |
| [9] | KIM V,ROGERS TJ,CRINER GJ.New concepts in the pathobiology of chronic obstructive pulmonary disease[J].Proc Am Thorac Soc,2008,5(4):478. |
| [10] | HOGG JC,CHU F,UTOKAPARCH S,et al.The nature of small-airway obstruction in chronic obstructive pulmonary disease[J].N Engl J Med,2004,350(26):2645. |
| [11] | KIM V,ROGERS TJ,CRINER GJ.Newconcepts in the pathobiology of chronic obstructive pulmonary disease[J].Proc Am Thorac Soc,2008,5(4):478. |
| [12] | BARNES NC,QIU YS,PAVORD ID,et al.Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease[J].Am J Respir Crit Care Med,2006,173(7):736. |
| [13] | PARR DG,WHITE AJ,BAYLEY DL,et al.Inflammation in sputum relates to progression of disease in subjects with COPD:a prospective descriptive study[J].Respir Res,2006,7(1):136. |
| [14] | 蔡晓婷,时国朝.慢性阻塞性肺病药物治疗现状[J].临床药物治疗杂志,2013,11(1):49. |
| [15] | MARCHIONI CF,MORETTI M,MURATORI M,et al.Effects of erdosteineon sputum biochemical and rheologic properties pharmacokineticsin chronic obstructive lung disease[J].Lung,1990,168(5):285. |
| [16] | DECHANT KL,NOBLE S.Erdosteine[J].Drugs,1996,52(6):875. |
| [17] | DAL NEGRO RW,VISCONTI M,TOGNELLA S,et al.Erdosteine affects eicosanoid production in COPD[J].Int J Clin Pharmacol Ther,2011,49(1):41. |